| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 187.021 | 188.753 | 191.822 | 194.731 | 435.240 | 464.408 | 598.516 | 600.545 | 791.887 | 1.172.974 |
| Venituri Totale - Ron | 187.359 | 189.082 | 192.193 | 195.283 | 435.893 | 464.871 | 600.593 | 601.206 | 793.318 | 1.187.882 |
| Cheltuieli Totale - Ron | 104.113 | 77.829 | 112.729 | 113.222 | 188.082 | 78.411 | 129.565 | 180.498 | 127.032 | 171.206 |
| Profit/Pierdere Brut - Ron | 83.246 | 111.253 | 79.464 | 82.061 | 247.811 | 386.460 | 471.028 | 420.708 | 666.286 | 1.016.676 |
| Profit/Pierdere Net - Ron | 67.557 | 91.851 | 63.597 | 80.109 | 243.452 | 381.305 | 465.231 | 415.693 | 554.542 | 842.692 |
| Salariati | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Verifica rapoartele financiare pentru firma - Atlaspharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 325.423 | 324.257 | 326.770 | 330.416 | 407.663 | 382.278 | 350.224 | 321.683 | 317.112 | 317.242 |
| Active Circulante | 151.035 | 163.435 | 60.969 | 145.492 | 121.680 | 368.833 | 671.751 | 828.880 | 1.192.686 | 1.578.157 |
| Stocuri | 0 | 4.113 | 7.729 | 99.499 | 0 | 0 | 0 | 0 | 0 | 4.488 |
| Creante | 0 | 0 | 0 | 0 | 222 | 340 | 4.424 | 2.542 | 19.704 | 3.034 |
| Casa si conturi | 151.035 | 159.322 | 53.240 | 45.993 | 121.458 | 368.493 | 667.327 | 826.338 | 1.172.982 | 1.570.635 |
| Capitaluri Proprii | 461.072 | 224.595 | 288.192 | 368.301 | 479.249 | 624.997 | 990.229 | 925.396 | 1.229.937 | 1.455.238 |
| Capital Social | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
| Datorii | 15.386 | 263.097 | 99.547 | 107.607 | 50.094 | 126.114 | 36.719 | 225.167 | 280.186 | 440.161 |
| Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "7112 - 7112" | |||||||||
| CAEN An Financiar |
7112
|
|||||||||
Comentarii - Atlaspharm S.r.l.